Diabetes Drug Questionnaire

Have you taken Januvia®, Victoza®, Janumet® or Byetta®?

Type two diabetes is a somewhat common condition in adults that often requires medication to properly manage. Studies have found that type 2 diabetes patients taking any of the drugs classified as incretin mimetics are potentially three times more likely to develop pancreatic cancer.

Pancreatic cancer diagnosis

If you have been diagnosed with pancreatic cancer or lost a loved one to pancreatic cancer after living with type 2 diabetes, you may want to review your medication history for these drugs. Our experienced medical attorneys are prepared to fight on your behalf if you've taken one of these drugs and developed pancreatic cancer.

We can help.

There are ongoing lawsuits that address patients that have developed pancreatic cancer after taking an incretin mimetic. If you or a loved one have been diagnosed with pancreatic cancer after taking one an incretin mimetic, contact us using the form below.

All consultations are free and come with zero obligations.

Name *

Telephone Number *

Email Address *

What state do you live in *

Did you or a loved one take one of these type 2 diabetes drugs? *

Januvia (sitagliptin)

Victoza (liraglutide)

Janumet (sitagliptin & metformin)

Byetta (exenatide)

^{Please note that we are not reviewing metformin only cases.}

Have you or a loved one been diagnosed with pancreatic cancer? *

No

Yes

Tell us about your potential case (500 character limit) *

By submitting this form, I agree that Motley Rice LLC may collect my information and use it pursuant to its privacy policy. *

If you do not agree with our website privacy policy please call 1.800.768.4026 to discuss your potential case.